Lymphoblastic Leukemia in Children Clinical Trials

7 clinical trials for Lymphoblastic Leukemia in Children across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children — RECRUITING · PHASE2
• A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia — RECRUITING · PHASE1
• CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol — RECRUITING · PHASE2
• CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia — RECRUITING · PHASE1
• Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia — OTHER · PHASE1
• ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. — OTHER · PHASE1
• Association Between Mitochondrial DNA Content and Risk of Acute Leukemia — COMPLETED

Refine this search